Journal
CARDIOVASCULAR RESEARCH
Volume 104, Issue 1, Pages 206-215Publisher
OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvu192
Keywords
Background K+ current; Beta-adrenoceptor; K-2P channel; Steady-state outward current; Osmotic stretch; TREK-1; Arachidonic acid
Categories
Funding
- British Heart Foundation [FS/10/68, PG/11/97, PG/10/91]
- British Heart Foundation
- British Heart Foundation [FS/10/68/28492, PG/10/91/28644, PG/11/97/29193] Funding Source: researchfish
Ask authors/readers for more resources
Aims Noradrenaline plays an important role in the modulation of atrial electrophysiology. However, the identity of the modulated channels, their mechanisms of modulation, and their role in the action potential remain unclear. This study aimed to investigate the noradrenergic modulation of an atrial steady-state outward current (I-Kss). Methods and results Rat atrial myocyte whole-cell currents were recorded at 36 degrees C. Noradrenaline potently inhibited I-Kss (IC50 = 0.90 nM, 42.1 +/- 4.3% at 1 mu M, n = 7) and potentiated the L-type Ca2+ current (I-CaL, EC50 = 136 nM, 205 +/- 40% at 1 mu M, n = 6). Noradrenaline-sensitive I-Kss was weakly voltage-dependent, time-independent, and potentiated by the arachidonic acid analogue, 5,8,11,14-eicosatetraynoic acid (EYTA; 10 mu m), or by osmotically induced membrane stretch. Noise analysis revealed a unitary conductance of 8.4 +/- 0.42 pS (n = 8). The biophysical/pharmacological properties of I-Kss indicate a TREK-like K+ channel. The effect of noradrenaline on I-Kss was abolished by combined beta(1)-/beta(2)-adrenoceptor antagonism (1 mu M propranolol or 10 mu M beta(1)-selective atenolol and 100 nM beta(2)-selective ICI-118,551 in combination), but not by beta 1- or 2-antagonist alone. The action of noradrenaline could be mimicked by beta(2)-agonists (zinterol and fenoterol) in the presence of beta(1)-antagonist. The action of noradrenaline on I-Kss, but not on I-CaL, was abolished by pertussis toxin (PTX) treatment. The action of noradrenaline on I-CaL was mediated by beta(1)-adrenoceptors via a PTX-insensitive pathway. Noradrenaline prolonged APD(30) by 52 +/- 19% (n = 5; P < 0.05), and this effect was abolished by combined beta(1)-/beta(2)-antagonism, but not by atenolol alone. Conclusion Noradrenaline inhibits a rat atrial TREK-like K+ channel current via a PTX-sensitive mechanism involving co-operativity of beta(1)-/beta(2)-adrenoceptors that contributes to atrial APD prolongation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available